Abivax S.A.’s Revenue Growth at a glance
Abivax S.A. reports revenue growth of 133.5% for Dec 2024. The prior period recorded 0.83% (Dec 2023). Year over year the metric moved +132.7 pts (+16,005.9%). The rolling three-period average stands at 4,140.3%. Data last refreshed Dec 7, 2025, 1:34 AM.
Latest reading
133.5% · Dec 2024
YoY movement
+132.7 pts (+16,005.9%)
Rolling average
4,140.3%
Current Revenue Growth
133.5%
+132.7 pts
+16,005.9%
Rolling average
4,140.3%
Latest Value
133.5%
Dec 2024
YoY Change
+132.7 pts
Absolute
YoY Change %
+16,005.9%
Rate of change
3-Period Avg
4,140.3%
Smoothed
Narrative signal
Abivax S.A.’s revenue growth stands at 133.5% for Dec 2024. Year-over-year, the metric shifted by +132.7 pts, translating into a +16,005.9% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How revenue growth shapes Abivax S.A.'s story
As of Dec 2024, Abivax S.A. reports revenue growth of 133.5%. Evaluate revenue acceleration, seasonality, and long-term expansion for U.S. equities using annual growth data.
How to read revenue growth
Consistent double-digit revenue growth typically indicates demand strength and market share gains. Sharp decelerations may point to competitive or macro headwinds.
Balancing growth with profitability
Growth only creates value when paired with improving margins or cash generation. Pair revenue growth with profitability metrics to judge overall health.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
100%
Operating Margin
-1,718.2%
Net Profit Margin
-1,633.1%
Return on Equity
-434.3%
Return on Assets
-85.9%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Abivax S.A. (ABVX) FAQs
Answers tailored to Abivax S.A.’s revenue growth profile using the latest Financial Modeling Prep data.
What is Abivax S.A.'s current revenue growth?
As of Dec 2024, Abivax S.A. reports revenue growth of 133.5%. This reading reflects the latest filings and price data for ABVX.
How is Abivax S.A.'s revenue growth trending year over year?
Year-over-year, the figure shifts by +132.7 pts (+16,005.9%). Pair this context with revenue growth and free cash flow signals to gauge momentum for ABVX.
Why does revenue growth matter for Abivax S.A.?
Revenue growth measures the percentage change in top-line sales compared with the prior period. For Abivax S.A., operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is Abivax S.A.'s revenue growth above its recent average?
Abivax S.A.'s rolling three-period average sits at 4,140.3%. Comparing the latest reading of 133.5% to that baseline highlights whether momentum is building or fading for ABVX.
How frequently is Abivax S.A.'s revenue growth refreshed?
Data for ABVX was last refreshed on Dec 7, 2025, 1:34 AM and updates automatically every 24 hours, keeping your valuation inputs current.